BioNTech SE (ETR:22UA)

Germany · Delayed Price · Currency is EUR

101.70

+6.60 (6.94%)

At close: Aug 21, 2026

Revenue Breakdown

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
COVID-19 Vaccine Revenue	1.83B	2.00B	2.43B
Out-Licensing Revenue	-	613.00M	-
Other Sales Revenue	209.20M	261.60M	319.00M
Revenue (Other)	389.30M	184.60M	140.60M
Revenue (Total)	2.43B	3.05B	2.89B